CELLGENUITY
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 Dec 2024)
What this means for you
Registered since 11 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87839617
- Registration number
- 5776870
- Mark type
- Stylized text
- Filed
- 19 Mar 2018
- Published for opposition
- 31 Jul 2018
- Registered
- 11 Jun 2019
- Attorney of record
- Carol M. Wilhelm
Goods and services
- Class 001 — Chemicals: Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use
- Class 005 — Pharmaceuticals: Biological tissue grafts; biological implants, namely, a vital processed human or animal connective tissue; biological placental tissue intended for subsequent implantation; human allograft tissue; human allograft bone and tissue; natural biomaterials for augmentation of bone and tissue for medical purposes
Owner
- Cellgenuity LLC, Grapevine, TX, US
- Cellgenuity LLC, Grapevine, TX, US
- Cellgenuity LLC, Grapevine, TX, US
Prosecution history
- 03 Dec 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Dec 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Dec 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 11 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 07 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Apr 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Mar 2019 — USE AMENDMENT FILED
- 07 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Mar 2019 — TEAS STATEMENT OF USE RECEIVED
- 25 Sept 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Jul 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jul 2018 — PUBLISHED FOR OPPOSITION